Loss of tau elicits axonal degeneration in a mouse model of Alzheimer's disease
暂无分享,去创建一个
M. Vitek | D. Laskowitz | Haichen Wang | H. Dawson | V. Cantillana | Marilyn Jansen | Donna M. Wilcock | John R. Lynch | D. M. Wilcock
[1] L. Mucke,et al. Epilepsy and cognitive impairments in Alzheimer disease. , 2009, Archives of neurology.
[2] L. Goldstein,et al. Amyloid precursor protein-induced axonopathies are independent of amyloid-beta peptides. , 2008, Human molecular genetics.
[3] Seth Love,et al. Long-term effects of Aβ42 immunisation in Alzheimer's disease: follow-up of a randomised, placebo-controlled phase I trial , 2008, The Lancet.
[4] J. Baron,et al. Relationships between Hippocampal Atrophy, White Matter Disruption, and Gray Matter Hypometabolism in Alzheimer's Disease , 2008, The Journal of Neuroscience.
[5] Oliver Wirths,et al. Deficits in working memory and motor performance in the APP/PS1ki mouse model for Alzheimer's disease , 2008, Neurobiology of Aging.
[6] S. Gross,et al. Tuning Microtubule‐Based Transport Through Filamentous MAPs: The Problem of Dynein , 2008, Traffic.
[7] Ram Dixit,et al. Differential Regulation of Dynein and Kinesin Motor Proteins by Tau , 2008, Science.
[8] M. Vitek,et al. The Tau N279K Exon 10 Splicing Mutation Recapitulates Frontotemporal Dementia and Parkinsonism Linked to Chromosome 17 Tauopathy in a Mouse Model , 2007, The Journal of Neuroscience.
[9] Kim N. Green,et al. Intracellular amyloid-β in Alzheimer's disease , 2007, Nature Reviews Neuroscience.
[10] L. Mucke,et al. Reducing Endogenous Tau Ameliorates Amyloid ß-Induced Deficits in an Alzheimer's Disease Mouse Model , 2007, Science.
[11] B. C. Carter,et al. Multiple-motor based transport and its regulation by Tau , 2007, Proceedings of the National Academy of Sciences.
[12] Yaakov Stern,et al. Incidence and Predictors of Seizures in Patients with Alzheimer's Disease , 2006, Epilepsia.
[13] Jacek Szczygielski,et al. Axonopathy in an APP/PS1 transgenic mouse model of Alzheimer’s disease , 2006, Acta Neuropathologica.
[14] Judianne Davis,et al. Reducing Cerebral Microvascular Amyloid-β Protein Deposition Diminishes Regional Neuroinflammation in Vasculotropic Mutant Amyloid Precursor Protein Transgenic Mice , 2005, The Journal of Neuroscience.
[15] Kefei Chen,et al. Behavioral phenotypes of amyloid‐based genetically modified mouse models of Alzheimer's disease , 2005, Genes, brain, and behavior.
[16] M. Vitek,et al. A novel therapeutic derived from apolipoprotein E reduces brain inflammation and improves outcome after closed head injury , 2005, Experimental Neurology.
[17] E. Masliah,et al. Axonopathy and Transport Deficits Early in the Pathogenesis of Alzheimer's Disease , 2005, Science.
[18] T. Bayer,et al. A modified β‐amyloid hypothesis: intraneuronal accumulation of the β‐amyloid peptide – the first step of a fatal cascade , 2004, Journal of neurochemistry.
[19] John Q Trojanowski,et al. Neurodegenerative diseases: a decade of discoveries paves the way for therapeutic breakthroughs , 2004, Nature Medicine.
[20] C. Broeckhoven,et al. The role of tau (MAPT) in frontotemporal dementia and related tauopathies , 2004, Human mutation.
[21] H. Mori,et al. The distributions of tau short and long isoforms fused with EGFP in cultured cells. , 2004, Osaka city medical journal.
[22] E. Mandelkow,et al. Clogging of axons by tau, inhibition of axonal traffic and starvation of synapses , 2003, Neurobiology of Aging.
[23] D. Holtzman,et al. Use of YFP to study amyloid-β associated neurite alterations in live brain slices , 2003, Neurobiology of Aging.
[24] N. Quinn,et al. Tau exon 10 +16 mutation FTDP-17 presenting clinically as sporadic young onset PSP , 2003, Neurology.
[25] Masanori Kato,et al. 4-repeat tauopathy sharing pathological and biochemical features of corticobasal degeneration and progressive supranuclear palsy , 2003, Acta Neuropathologica.
[26] J. Sanes,et al. PDAPP; YFP double transgenic mice: A tool to study amyloid‐β associated changes in axonal, dendritic, and synaptic structures , 2003, The Journal of comparative neurology.
[27] W. Kamphorst,et al. Impaired axonal transport of cortical neurons in Alzheimer’s disease is associated with neuropathological changes , 2002, Brain Research.
[28] John T. Finn,et al. Axonal Self-Destruction and Neurodegeneration , 2002, Science.
[29] M. Vitek,et al. Tau is essential to β-amyloid-induced neurotoxicity , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[30] E. Mandelkow,et al. Tau blocks traffic of organelles, neurofilaments, and APP vesicles in neurons and enhances oxidative stress , 2002, The Journal of cell biology.
[31] H. Benveniste,et al. Apolipoprotein E affects the central nervous system response to injury and the development of cerebral edema , 2002, Annals of neurology.
[32] J. Olney,et al. Apoptosis in the in Vivo Mammalian Forebrain , 2001, Neurobiology of Disease.
[33] D. Diamond,et al. Correlation between cognitive deficits and Aβ deposits in transgenic APP+PS1 mice , 2001, Neurobiology of Aging.
[34] M. Vitek,et al. Inhibition of neuronal maturation in primary hippocampal neurons from tau deficient mice. , 2001, Journal of cell science.
[35] J. Trojanowski,et al. Loss of brain tau defines novel sporadic and familial tauopathies with frontotemporal dementia , 2001, Annals of neurology.
[36] M. Hutton,et al. Phenotypic correlations in FTDP-17 , 2001, Neurobiology of Aging.
[37] J. Hardy,et al. Aβ peptide vaccination prevents memory loss in an animal model of Alzheimer's disease , 2000, Nature.
[38] Ralph A. Nixon,et al. Aβ peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease , 2000, Nature.
[39] J. Guralnik,et al. Documented head injury in early adulthood and risk of Alzheimer’s disease and other dementias , 2000, Neurology.
[40] E. Mandelkow,et al. Structure, microtubule interactions, and paired helical filament aggregation by tau mutants of frontotemporal dementias. , 2000, Biochemistry.
[41] L. Schmued,et al. Fluoro-Jade B: a high affinity fluorescent marker for the localization of neuronal degeneration , 2000, Brain Research.
[42] Patrick R. Hof,et al. Tau protein isoforms, phosphorylation and role in neurodegenerative disorders 1 1 These authors contributed equally to this work. , 2000, Brain Research Reviews.
[43] R. Motter,et al. Peripherally administered antibodies against amyloid β-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease , 2000, Nature Medicine.
[44] R. A. Crowther,et al. Axonopathy and amyotrophy in mice transgenic for human four-repeat tau protein , 2000, Acta Neuropathologica.
[45] J. Kuret,et al. In vitro polymerization of tau protein monitored by laser light scattering: method and application to the study of FTDP-17 mutants. , 2000, Biochemistry.
[46] C. DeCarli,et al. Head injury and the risk of AD in the MIRAGE study , 2000, Neurology.
[47] A. Fagan,et al. Apolipoprotein E isoform-dependent amyloid deposition and neuritic degeneration in a mouse model of Alzheimer's disease. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[48] Jacqueline N. Crawley,et al. What's Wrong With My Mouse?: Behavioral Phenotyping of Transgenic and Knockout Mice , 2000 .
[49] T. Révész,et al. Neuronal cytoskeletal changes are an early consequence of repetitive head injury , 1999, Acta Neuropathologica.
[50] R. Motter,et al. Immunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse , 1999, Nature.
[51] J. Mcculloch,et al. Drug development for stroke: importance of protecting cerebral white matter. , 1999, European journal of pharmacology.
[52] S. Lovestone,et al. Mutations in tau reduce its microtubule binding properties in intact cells and affect its phosphorylation , 1999, FEBS letters.
[53] A. Delacourte,et al. Neurofibrillary Degeneration in Progressive Supranuclear Palsy and Corticobasal Degeneration , 1999, Journal of neurochemistry.
[54] John X. Morris,et al. Mutation-specific functional impairments in distinct tau isoforms of hereditary FTDP-17. , 1998, Science.
[55] E. Mandelkow,et al. Overexpression of Tau Protein Inhibits Kinesin-dependent Trafficking of Vesicles, Mitochondria, and Endoplasmic Reticulum: Implications for Alzheimer's Disease , 1998, The Journal of cell biology.
[56] M. Goedert,et al. Tau proteins with FTDP‐17 mutations have a reduced ability to promote microtubule assembly , 1998, FEBS letters.
[57] D. Ingram,et al. Stereological estimation of total microglia number in mouse hippocampus , 1998, Journal of Neuroscience Methods.
[58] K. Nave,et al. Axonal swellings and degeneration in mice lacking the major proteolipid of myelin. , 1998, Science.
[59] B. Hyman,et al. APPSW Transgenic Mice Develop Age‐related Aβ Deposits and Neuropil Abnormalities, but no Neuronal Loss in CA1 , 1997, Journal of neuropathology and experimental neurology.
[60] T. Kamei,et al. Amyotrophic lateral sclerosis with numerous axonal spheroids in the corticospinal tract and massive degeneration of the cortex , 1997, Acta Neuropathologica.
[61] S. Younkin,et al. Correlative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic Mice , 1996, Science.
[62] R. Terry. The pathogenesis of Alzheimer disease: an alternative to the amyloid hypothesis. , 1996, Journal of neuropathology and experimental neurology.
[63] L. Mucke,et al. Comparison of Neurodegenerative Pathology in Transgenic Mice Overexpressing V717F β-Amyloid Precursor Protein and Alzheimer’s Disease , 1996, The Journal of Neuroscience.
[64] A. Faissner,et al. Tau Binds to the Distal Axon Early in Development of Polarity in a Microtubule- and Microfilament-Dependent Manner , 1996, The Journal of Neuroscience.
[65] I. Fischer,et al. Tau Is Enriched on Dynamic Microtubules in the Distal Region of Growing Axons , 1996, The Journal of Neuroscience.
[66] J. Geddes,et al. Neurofibrillary tangles, but not Alzheimer‐type pathology, in a young boxer , 1996, Neuropathology and applied neurobiology.
[67] J. Olney,et al. MK-801 neurotoxicity in male mice: histologic effects and chronic impairment in spatial learning , 1996, Brain Research.
[68] A. Marmarou,et al. A new model of diffuse brain injury in rats. Part I: Pathophysiology and biomechanics. , 1994, Journal of neurosurgery.
[69] T. Deerinck,et al. Re‐Evaluation of the Structural Organization of Neuritic Plaques in Alzheimer's Disease , 1993 .
[70] Roland S. G. Jones. Entorhinal-hippocampal connections: a speculative view of their function , 1993, Trends in Neurosciences.
[71] H. Gundersen,et al. Unbiased stereological estimation of the total number of neurons in the subdivisions of the rat hippocampus using the optical fractionator , 1991, The Anatomical record.
[72] K. Kosik,et al. Inhibition of neurite polarity by tau antisense oligonucleotides in primary cerebellar neurons , 1990, Nature.
[73] A. Frankfurter,et al. The distribution of tau in the mammalian central nervous system , 1985, The Journal of cell biology.
[74] L M Schuman,et al. Head injury as a risk factor for Alzheimer's disease , 1985, Neurology.
[75] W E Wilkinson,et al. Alzheimer's disease: A study of epidemiological aspects , 1984, Annals of neurology.
[76] M. Kirschner,et al. Studies on the expression of the microtubule-associated protein, tau, during mouse brain development, with newly isolated complementary DNA probes , 1984, The Journal of cell biology.
[77] M. Kirschner,et al. A protein factor essential for microtubule assembly. , 1975, Proceedings of the National Academy of Sciences of the United States of America.
[78] W. R. Ingram,et al. An improved cupric-silver method for impregnation of axonal and terminal degeneration. , 1971, Brain research.
[79] H. Qing,et al. Valproic acid inhibits Aβ production, neuritic plaque formation, and behavioral deficits in Alzheimer's disease mouse models , 2008, The Journal of Experimental Medicine.
[80] M. Asunción Morán,et al. Ultrastructural localization of intraneuronal Abeta-peptide in Alzheimer disease brains. , 2007, Journal of Alzheimer's disease : JAD.
[81] R. Berry,et al. Conformational changes and truncation of tau protein during tangle evolution in Alzheimer's disease. , 2003, Journal of Alzheimer's disease : JAD.
[82] Dennis W. Dickson,et al. Tau accumulation in astrocytes in progressive supranuclear palsy is a degenerative rather than a reactive process , 2002, Acta Neuropathologica.
[83] B. Jordan,et al. Chronic Traumatic Brain Injury Associated with Boxing , 2000, Seminars in neurology.
[84] M. Goedert,et al. The tauopathies: toward an experimental animal model. , 1999, The American journal of pathology.
[85] B. Pike,et al. The rotarod test: an evaluation of its effectiveness in assessing motor deficits following traumatic brain injury. , 1994, Journal of neurotrauma.